Scholarlink

<p>Following the rapid and successful deployment of the mRNA-based, lipid nanoparticle-delivered COVID-19 vaccines, lipid-based drug delivery systems became integral to mainstream medicine. To support continued advancement of such systems, we developed three relevant anionic nanoparticle reference materials, which were thoroughly characterized and certified for mean particle hydrodynamic diameter with additional reference and informational values provided. The certified reference materials comprise one liposome formulation (ALIPO-1) and two distinct siRNA-loaded lipid nanoparticle formulations (ALNP-1 and LNP-2), each exhibiting a monodisperse particle population. The certified mean hydrodynamic diameter (Z-average) and the associated expanded uncertainty are, respectively, equal to (90.8 ± 1.2) nm, (123.2 ± 1.5) nm, and (68.8 ± 1.6) nm; the corresponding polydispersity index (PdI) and expanded uncertainty values are 0.054 ± 0.017, 0.041 ± 0.008, and 0.083 ± 0.020. The formulations are stored long-term at −70&#xa0;°C and are projected to maintain size stability for several years. When dispersed, they also demonstrate sufficient short- to medium-term stability to support a range of biological and biomedical applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lipid nanoparticle and liposome certified reference materials: ALIPO-1, ALNP-1, and LNP-2

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月8日

查看全文
  • Zygmunt J. Jakubek,
  • Myla Weiman,
  • Sadman Sakib,
  • Shan Zou

摘要

Following the rapid and successful deployment of the mRNA-based, lipid nanoparticle-delivered COVID-19 vaccines, lipid-based drug delivery systems became integral to mainstream medicine. To support continued advancement of such systems, we developed three relevant anionic nanoparticle reference materials, which were thoroughly characterized and certified for mean particle hydrodynamic diameter with additional reference and informational values provided. The certified reference materials comprise one liposome formulation (ALIPO-1) and two distinct siRNA-loaded lipid nanoparticle formulations (ALNP-1 and LNP-2), each exhibiting a monodisperse particle population. The certified mean hydrodynamic diameter (Z-average) and the associated expanded uncertainty are, respectively, equal to (90.8 ± 1.2) nm, (123.2 ± 1.5) nm, and (68.8 ± 1.6) nm; the corresponding polydispersity index (PdI) and expanded uncertainty values are 0.054 ± 0.017, 0.041 ± 0.008, and 0.083 ± 0.020. The formulations are stored long-term at −70 °C and are projected to maintain size stability for several years. When dispersed, they also demonstrate sufficient short- to medium-term stability to support a range of biological and biomedical applications.